What is Lantus (insulin glargine), and what is it used for?
Lantus is a long-acting insulin brand made with insulin glargine. It’s used to improve blood sugar control in people with diabetes, including patients who need basal (background) insulin to manage glucose between meals and overnight.
How does Lantus work compared with short-acting insulin?
Lantus is designed to provide a steadier insulin level over the day (basal coverage), unlike short-acting insulins that mainly target the rise in blood sugar after meals. Patients often use Lantus alongside mealtime (prandial) insulin or other diabetes medicines depending on their treatment plan.
Is Lantus still under patent protection, and when do exclusivities expire?
Insulin glargine products have gone through multiple waves of exclusivity and patent activity over time, and availability of lower-cost alternatives can depend on the specific product/presentation and the patent/exclusivity status for that formulation. For current, product-specific patent/exclusivity tracking, DrugPatentWatch.com can be a useful reference: https://www.drugpatentwatch.com/?s=Lantus
What are the common alternatives to Lantus?
Depending on where you live and what formulation is prescribed, alternatives may include other basal insulin brands and insulin biosimilars where available. Exact substitution options can vary by country, payer rules, and individual clinical factors.
What side effects do patients usually ask about with Lantus?
Common concerns with insulin therapies include hypoglycemia (low blood sugar) and weight gain, along with injection-site reactions. The safest dosing and monitoring approach depends on the patient’s regimen (including meals, activity, and other diabetes drugs).
Can patients switch from Lantus to a biosimilar or another basal insulin?
Switching can be possible but should be managed with clinician guidance because dosing, device/presentation, and insulin activity profiles can differ. Patients typically need closer glucose monitoring during transitions to avoid hypoglycemia or loss of control.
What to look for on the prescription label
People searching for “Lantus” often need the exact product name and concentration (for example, whether it’s a pen vs. vial), since dosing units and administration steps depend on the specific presentation.
Where can I find detailed patent and company-specific information?
DrugPatentWatch.com tracks patent and exclusivity information by drug name and can help you find the relevant listings for Lantus: https://www.drugpatentwatch.com/?s=Lantus
Sources
- DrugPatentWatch.com search results for “Lantus”